Comparison of percutaneous device closure versus surgical closure of peri-membranous ventricular septal defects: A systematic review and meta-analysis

2015 ◽  
Vol 86 (6) ◽  
pp. 1048-1056 ◽  
Author(s):  
Alok Saurav ◽  
Manu Kaushik ◽  
Venkata Mahesh Alla ◽  
Michael D. White ◽  
Ruby Satpathy ◽  
...  
2021 ◽  
pp. 1-7
Author(s):  
Mahua Roy ◽  
Debasree Gangopadhyay ◽  
Noopur Goyal ◽  
Savita Murthy ◽  
Debabrata Nandi ◽  
...  

Abstract Objective: To assess the feasibility of percutaneous transcatheter device closure of ventricular septal defects in children weighing less than 10 kg. Background: Although percutaneous transcatheter device closure of ventricular septal defect is a well-established method of treatment in older children and adolescents, there is limited data on device closure in small children weighing less than 10 kg. We present our institutional experience of transcatheter VSD closure in children weighing less than 10 kg. Method: Medical records were reviewed for 16 children, who were selected for device closure of ventricular septal defects based on the inclusion criteria. Results: Out of 65 patients with a diagnosis of ventricular septal defect, 16 children less than 10 kg were attempted for percutaneous device closure. In 13 patients, the device was successfully released, and 3 patients needed surgical closure of the defect. Mean age and weight of the patients were 17.3 ± 12.7 months and 6.8 ± 3.2 kg, respectively. Mean defect size was 6 mm (range 3–10). There was no incidence of device embolisation or heart block or death. Five patients had residual left-to-right shunt immediately after the device release, which got closed by the first month’s follow-up. We had one accidental perforation of right ventricular free wall at the time of crossing of the defect, which was successfully repaired surgically. Conclusion: Percutaneous device closure of ventricular septal defect in small children with weight below 10 kg is feasible with good short-term outcome. Careful patient selection is essential for procedural success and to avoid complications.


2010 ◽  
Vol 77 (2) ◽  
pp. 260-267 ◽  
Author(s):  
Wail Al-Kashkari ◽  
Prakash Balan ◽  
Clifford J. Kavinsky ◽  
Qi-Ling Cao ◽  
Ziyad M. Hijazi

2020 ◽  
Vol 41 (Supplement_2) ◽  
Author(s):  
H Bu ◽  
Y Yang ◽  
Q Wu ◽  
W Zhang ◽  
S Hu ◽  
...  

Abstract Background Traditional percutaneous device closure of perimembranous ventricular septal defects (PmVSDs) is a minimally invasive technique, but can result in high radiation exposure and potential arterial complications. The feasibility of another alternative surgical repair technique for closure of VSDs by percardiac device has been proven. However, the disadvantages of surgical trauma and incision in the inferior sternum cannot avoid. Purpose In an effort to avoid radiation exposure, arterial access, surgical incision and complications, we established a novel technique for transcatheter VSD closure via the femoral vein approach under the guidance of transesophageal echocardiography (TEE) without fluoroscopy. And the feasibility and safety of this new strategy have been assessed. Methods From January 2015 to June 2019, a total of 48 PmVSD patients (mean age, 7.5±2.4 years [range, 4.3– 12.0 years]; mean body weight 24.6±6.8 kg [range, 16.5–38.5 kg]; VSD diameter, 4.3±0.6 mm [range, 3.2–5.0 mm]) underwent attempted transcatheter closure via the femoral vein approach under the guidance of TEE without fluoroscopy. Results The transcatheter occlusion procedure under TEE guidance was successful in 46 (95.8%) patients. Surgery was necessary in 2 (4.2%) patients. The mean procedural duration, post-operative mechanical ventilation duration, intensive care unit (ICU) residence, and in-hospital durations were 27.2±7.4 min (range, 12.0–42.0 min), 63.2±5.3 min (range, 56.0–78.0 min), 2.1±0.1 h (mean, 2.0–2.4 h), and 2.7±0.3 d (range, 2.5–3.0 d), respectively. One patient had immediate post-operative trivial residual shunt and four patients had immediate incomplete right bundle branch block (IRBBB) after operation; the new IRBBB in 2 cases were noted in the first postoperative month. No residual shunt was noted at 3 months after the procedure, and no intervention related complications were detected at 1–36 months follow-up. Conclusion Echocardiography-guided percutaneous device closure of PmVSDs solely by femoral vein approach is effective and safe, avoids radiation exposure, potential arterial complications and a surgical incision. Procedure of percutaneous closure PmVSD Funding Acknowledgement Type of funding source: Foundation. Main funding source(s): The Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry.


2020 ◽  
Vol 41 (3) ◽  
pp. 591-598 ◽  
Author(s):  
Varsha Walavalkar ◽  
Shreesha Maiya ◽  
Suresh Pujar ◽  
Prakash Ramachandra ◽  
Satheesh Siddaiah ◽  
...  

2011 ◽  
Vol 7 (3) ◽  
pp. 377-385 ◽  
Author(s):  
Gianfranco Butera ◽  
Giuseppe Biondi-Zoccai ◽  
Giuseppe Sangiorgi ◽  
Raul Abella ◽  
Alessandro Giamberti ◽  
...  

2019 ◽  
Vol 1 (2) ◽  
pp. 8-13
Author(s):  
Sergiu Vijiala ◽  
Eric Eeckhout ◽  
Grégoire Girod ◽  
Grégoire Girod

Percutaneous device closure of atrial septal defects (ASD) has proven to be safe and it is nowadays the standard treatment for ASDs. Immediate or late device embolization is a rare but potential complication of every attempted ASD device closure. We report a case of asymptomatic Amplatzer Septal Occluder into the left ventricular outflow tract (LVOT) detected by routine transthoracic echocardiography 3 months after successful implantation in a stable patient.


2020 ◽  
Vol 27 ◽  
pp. 100490
Author(s):  
Vishal Vyas ◽  
Amit Kaura ◽  
Vinit Sawhney ◽  
Martin Lowe ◽  
Vivienne Ezzat

2020 ◽  
Vol 15 (1) ◽  
Author(s):  
Jiang-Shan Huang ◽  
Kai-Peng Sun ◽  
Shu-Ting Huang ◽  
Qiang Chen ◽  
Liang-Wan Chen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document